A recent study by Quian and colleagues showed that CK18 (M65) was independently and positively associated with cardiometabolic disorders, even after adjustment for the presence of NAFLD and other cardiovascular risk factors [29]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.